Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sparano

Showing results (221-230 of 655) with videos related to

Pageof 66
Sort By:
Medical Oncology (Northwood, London, England)|January 1, 1994
Adjuvant radiotherapy for breast cancer as a risk factor for the development of lung cancerP H Wiernik, N T Sklarin, J P Dutcher, et al.
Breast Cancer Research and Treatment|June 16, 2009
Recommendations for research priorities in breast cancer by the Coalition of Cancer Cooperative Groups Scientific Leadership Council: systemic therapy and therapeutic individualizationJoseph A Sparano, Gabriel N Hortobagyi, Julie R Gralow, et al.
Clinical Breast Cancer|March 20, 2002
Microvessel density and p53 overexpression in young women with breast cancer: a case-control studyB Kalfon, S Fineberg, Y Gu, et al.
Bone Marrow Transplantation|January 1, 1995
Pilot study of high-dose mitoxantrone and busulfan plus autologous bone transplantation in patients with advanced malignanciesA Khalil, N Ciobanu, J A Sparano, et al.
Panminerva Medica|October 1, 1979
12 h profile of plasma renin activity and angiotensin II like activity in Cushing's syndromeC Tosti-Croce, F Sparano, G Giaquinto, et al.
Blood|August 15, 2002
Phase 2 trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with poor-prognosis, intermediate-grade non-Hodgkin lymphoma: an Eastern Cooperative Oncology Group trial (E3493)Joseph A Sparano, Edie Weller, Tipu Nazeer, et al.
Cancer Medicine|August 27, 2020
Investigating the impact of open label design on patient-reported outcome results in prostate cancer randomized controlled trialsGuillaume Mouillet, Fabio Efficace, Antoine Thiery-Vuillemin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 3, 1999
Effect of highly active antiretroviral therapy on the incidence of HIV-associated malignancies at an urban medical centerJ A Sparano, K Anand, J Desai, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 28, 2021
Investigating Trends in the Quality of Reporting of Patient-Reported Outcomes in Oncology Over Time: Analysis of 631 Randomized Controlled Trials Published Between 2004 and 2019Fabio Efficace, Johannes M Giesinger, David Cella, et al.
Breast Cancer Research and Treatment|February 19, 2013
Mitotic counts in breast cancer after neoadjuvant systemic chemotherapy and development of metastatic diseaseJanice Diaz, Lesley Stead, Nella Shapiro, et al.
Pageof 66

Showing results (221-230 of 655) with videos related to

Sort By:
Pageof 66
Medical Oncology (Northwood, London, England)|January 1, 1994
Adjuvant radiotherapy for breast cancer as a risk factor for the development of lung cancerP H Wiernik, N T Sklarin, J P Dutcher, et al.
Breast Cancer Research and Treatment|June 16, 2009
Recommendations for research priorities in breast cancer by the Coalition of Cancer Cooperative Groups Scientific Leadership Council: systemic therapy and therapeutic individualizationJoseph A Sparano, Gabriel N Hortobagyi, Julie R Gralow, et al.
Clinical Breast Cancer|March 20, 2002
Microvessel density and p53 overexpression in young women with breast cancer: a case-control studyB Kalfon, S Fineberg, Y Gu, et al.
Bone Marrow Transplantation|January 1, 1995
Pilot study of high-dose mitoxantrone and busulfan plus autologous bone transplantation in patients with advanced malignanciesA Khalil, N Ciobanu, J A Sparano, et al.
Panminerva Medica|October 1, 1979
12 h profile of plasma renin activity and angiotensin II like activity in Cushing's syndromeC Tosti-Croce, F Sparano, G Giaquinto, et al.
Blood|August 15, 2002
Phase 2 trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with poor-prognosis, intermediate-grade non-Hodgkin lymphoma: an Eastern Cooperative Oncology Group trial (E3493)Joseph A Sparano, Edie Weller, Tipu Nazeer, et al.
Cancer Medicine|August 27, 2020
Investigating the impact of open label design on patient-reported outcome results in prostate cancer randomized controlled trialsGuillaume Mouillet, Fabio Efficace, Antoine Thiery-Vuillemin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 3, 1999
Effect of highly active antiretroviral therapy on the incidence of HIV-associated malignancies at an urban medical centerJ A Sparano, K Anand, J Desai, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 28, 2021
Investigating Trends in the Quality of Reporting of Patient-Reported Outcomes in Oncology Over Time: Analysis of 631 Randomized Controlled Trials Published Between 2004 and 2019Fabio Efficace, Johannes M Giesinger, David Cella, et al.
Breast Cancer Research and Treatment|February 19, 2013
Mitotic counts in breast cancer after neoadjuvant systemic chemotherapy and development of metastatic diseaseJanice Diaz, Lesley Stead, Nella Shapiro, et al.
Pageof 66